retatrutide dosage trials Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Clinical Retatrutide Starting Dose: What Clinical

Steps in the process: How we approve medicines

Wegovy pill The Wegovy pill is made by Novo Nordisk, the same manufacturer behind injectable Wegovy and Ozempic, as well as oral Rybelsus

This is the first Phase 3 GLP-1-class readout that specifically demonstrates symptomatic benefit in knee osteoarthritis beyond what would be expected from weight loss alone, and it opens the possibility, still to be confirmed in dedicated trials, that GLP-1 receptor signaling has direct anti-inflammatory or disease-modifying effects on joint tissue

However, there is no official clinical evidence establishing superior weight loss outcomes based on injection timing alone